1. TFOS Ambassadors

Spain

Jose Benitez del Castillo Sanchez

Prof. José Benítez-del-Castillo works at Complutense University of Madrid, Hospital Universitario Clínico San Carlos, Clínica Ocumed-Rementería, Madrid, Spain.
 
He is Professor and Chairman of Ophthalmology at Complutense University of Madrid and Director of the Ocular Surface and Inflammation Unit at Hospital Universitario Clínico San Carlos in Madrid, Spain. He trained at the University of Cádiz, Spain and was awarded his PhD in 1992 from the Complutense University of Madrid.
 
Prof. Benítez-del-Castillo has been the Editor of the Spanish journal Archivos de la Sociedad Española de Oftalmología, and Associate Editor of Ophthalmic Research and he is currently Member of the Editorial Board of the Journal of Optometry and the Turkish and Polish Journal of Ophthalmology.
 
He is General Secretary of the European Dry Eye Society (EuDES). He is also President of the Spanish Society of Ophthalmology (SEO), Country liason for the Tear Film and Ocular Surface Society (TFOS), and President of the Spanish Society of Ocular Surface and Cornea (SESOC).
 
Prof. Benítez-del-Castillo is a reviewer for more than ten scientific journals, including Ocular Surface, Ophthalmology, and the Lancet, and has published more than 250 papers, contributed to several books and presented more than 650 posters and oral presentations at international conferences. He has participated in the meibomian gland dysfunction, DEWS II and III, and life style TFOS workshops.
 
< back

20 April

TFOS Guidelines

Ocular surface disease (OSD)—including dry eye disease, blepharitis, meibomian gland dysfunction, conjunctival inflammation, and cicatrizing ocular surface disorders—is one of the most common and underrecognized factors affecting the success of eye surgery (e.g., refractive, cataract, glaucoma, strabismus, retina, and oculoplastic). Conversely, optimizing the ocular surface is one of the most effective, modifiable strategies for enhancing surgical success across all ophthalmic subspecialties. And the central clinical principle appears to be universal: elective eye surgery...

17 April

EssilorLuxottica Partners with TFOS to Advance Ocular Surface Health Worldwide

TFOS is pleased to announce a new strategic partnership with EssilorLuxottica, a global leader in vision care and eyewear. This collaboration will support shared efforts to elevate awareness, education, and scientific progress in tear film and ocular surface health worldwide. By combining TFOS’s expertise in evidence-based consensus and professional education with EssilorLuxottica’s global reach and innovation capabilities, the partnership aims to help improve standards of care for patients affected by dry eye disease and related ocular surface conditions. Together, TFOS and EssilorLuxottica...

10 February

Latin American TFOS Ambassador Meeting

TFOS has organized a special meeting of the Latin American TFOS Ambassadors. This meeting, which will occur in Panama City this May, has two goals: first, to address the unmet needs for the management (e.g. diagnosis & treatment) of ocular surface diseases in their country/region, as well as what the Ambassadors perceive as short and long term scientific/clinical solutions; and second, to create a report for publication in a peer-reviewed journal. Participants will include TFOS Ambassadors from Argentina, Bolivia, Brazil, Chile, Colombia, Costa Rica, Ecuador, El Salvador, Guatemala, Honduras,...

Corporate Advisory Board Members